Laboratory Investigation

Kidney International (1990) 37, 717–726; doi:10.1038/ki.1990.38

Activation of the inflammatory response of neutrophils by Tamm-Horsfall glycoprotein

Jeffrey K Horton1, Malcolm Davies1, Nicholas Topley1, David Thomas1 and John D Williams1

1K.R.U.F. Institute of Renal Disease, University of Wales College of Medicine, Royal Infirmary, Cardiff CF2 1SZ, Wales, United Kingdom

Correspondence: Dr Malcolm Davies, K.R.U.F. Institute of Renal Disease, University of Wales College of Medicine, Royal Infirmary, Cardiff, CF2 1SZ, Wales, United Kingdom.

Received 13 March 1989; Revised 23 August 1989; Accepted 1 September 1989.

Top

Abstract

Activation of the inflammatory response of neutrophils by Tamm-Horsfall glycoprotein. The activation of human polymorphonuclear leukocytes (PMN) by particulate Tamm-Horsfall glycoprotein (THG) represents an interaction hitherto unrecognized. The potential pathophysiological effect of this phenomenon within the interstitium of the kidney is highlighted by the activation of the respiratory burst, as well as by comprehensive PMN degranulation. Products of the interaction are expressed in terms of phagocytosis, luminol-dependent chemiluminescence, granule marker enzyme release and arachidonic acid metabolism. Significant quantities of the primary, secondary and tertiary granule markers, myeloperoxidase, vitamin B12 binding protein and N-acetyl-beta-D-glucosaminidase, respectively, were secreted in a dose and time-dependent manner. Phagocytosis of the glycoprotein was accompanied by the generation of significant quantities of leukotriene B4. Furthermore, the ability of such a particulate ligand to activate the alternative pathway of complement clearly represents a capacity to augment the inflammatory response. Should the interaction of THG with PMN take place within the interstitium of the kidney, augmented by the deposition of complement proteins on the surface of insoluble aggregates, the resulting inflammatory response may lead to marked tissue damage and eventually result in interstitial fibrosis.

Top

References

  1. Cornelius CE, Mia AS, Rosenfeld S: Studies on the origin of Tamm-Horsfall urinary mucoprotein and its presence in ovine calculous matrix. Invest Urol 2:453–457, 1965
  2. Avis PJG: The development of a radioimmunoassay procedure for the estimation of Tamm-Horsfall glycoprotein in human serum. Clin Sci 52:183–191, 1977
  3. Dawnay A, McLean C, Cattell WE: The development of a radioimmunoassay for Tamm-Horsfall glycoprotein in serum. Biochem J 1985:679–687, 1980
  4. Dawnay A, Thornley C, Cattell WR: An improved radioimmunoassay for urinary Tamm-Horsfall glycoprotein. Biochem J 206:461–465, 1982 | PubMed |
  5. Hunt JS, McGiven AR, Groufsky A, Lynn KL, Taylor MC: Affinity purified antibodies of defined specificity for use in a solid-phase microplate radioimmunoassay of human Tamm-Horsfall protein in urine. Biochem J 227:957–963, 1985 | PubMed | ISI | ChemPort |
  6. Goodall AA, Marshall RD: Effects of freezing on the estimated amounts of Tamm-Horsfall glycoprotein in urine, as determined by radioimmunoassay. Biochem J 189:533–539, 1980
  7. Horton JK, Davies M, Woodhead JS, Weeks I: A new and rapid immunochemiluminometric assay for the measurement of Tamm-Horsfall glycoprotein. Clinica Chimica Acta 174:225–238, 1988
  8. Fletcher AP: The Tamm and Horsfall glycoprotein, in Glycoproteins: Their Composition, Structure and Function, edited by A. Gottschalk, North Holland, Elsevier, 1972, pp. 892–908
  9. Sikri KL, Foster CL, Bloomfied FJ, Marshall RD: Localisation by immunofluorescence and by light and electron microscopic immunoperoxidase techniques of Tamm-Horsfall glycoprotein in adult hamster kidney. Biochem J 181:525–532, 1979 | PubMed | ISI | ChemPort |
  10. Sikri KL, Foster CL, MacHugh N, Marshall RD: Localization of Tamm-Horsfall glycoprotein in the human kidney using immunofluorescence and immunoelectron microscopical techniques. J Anat 132:597–605, 1981 | PubMed | ISI | ChemPort |
  11. Kumar S, Jasani B, Hunt JS, Moffatt DB, Asscher AW: A system for accurate immunolocalization of Tamm-Horsfall in renal biopsies. Histochem J 17:1251–1258, 1985 | Article | PubMed | ISI | ChemPort |
  12. Hoyer JR, Seiler MW: Pathophysiology of Tamm-Horsfall protein. Kidney Int 16:279–289, 1979 | PubMed | ISI | ChemPort |
  13. Lynn KL: Tamm-Horsfall glycoprotein. What relevance to health and disease? NZ Med J 95:457–1458, 1982
  14. Shachner MS, Miniter PM, Mayrer AR, Andriole VT: Interaction of Tamm-Horsfall protein with bacterial extracts. Kidney Int 31:77–84, 1987
  15. Zager RA, Cotran RS, Hoyer JR: Pathologic localization of Tamm-Horsfall protein in interstitial deposits in renal disease. Lab Invest 38:52–57, 1978 | PubMed | ISI | ChemPort |
  16. Resnick JS, Sisson S, Vernier RL: Tamm-Horsfall protein: Abnormal localization in renal disease. Lab Invest 38:550–555, 1978 | PubMed | ISI | ChemPort |
  17. Cotran RS, Galvanck E: Immunopathology of human tubule interstitial diseases: Localization of immunoglobulin, complement and Tamm-Horsfall protein. Contr Nephol 16:126–131, 1979
  18. Mayrer AR, Kashgarin M, Ruddle NH, Manier R, Hodson CJ, Richards FF, Andriole VT: Tubulointerstitial nephritis and immunologic responses to Tamm-Horsfall protein in rabbits challenged with homologous urine of Tamm-Horsfall protein. J Immunol 128:2634–2642, 1982 | PubMed | ISI | ChemPort |
  19. Nagai T, Nagai T: Tubulointerstitial nephritis by Tamm-Horsfall glycoprotein or egg white component. Nephron 47:137–140, 1987
  20. Hoyer JR: Tubulointerstitial immune complex nephritis in rats immunized with Tamm-Horsfall protein. Kidney Int 17:284–292, 1980 | PubMed | ISI | ChemPort |
  21. Mampaso FM, Wilson CB: Characterization of inflammatory cells in autoimmune tubulointerstitial nephritis in rats. Kidney Int 23:448–457, 1983 | PubMed | ISI | ChemPort |
  22. Kiernan JA: Histological and Histochemical Methods, Theory and Practice. London, Academic Press, 1981
  23. Foidart J-M, Timpl R, Furthmayr H, Martin GT: Laminin, a glycoprotein from basement membranes, in Immunochemistry of the Extracellular Matrix, edited by Furthmayr H, London, CRC Press, 1982, pp. 125–134
  24. Tamm I, Horsfall FL: A mucoprotein derived from normal urine which reacted with influenza, mumps and Newcastle disease virus. J Exp Med 95:71–79, 1952 | PubMed | ISI | ChemPort |
  25. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature (London) 227:680–685, 1970 | Article | PubMed | ChemPort |
  26. Reinhold R, Fine J: A technique for quantitative measurement of endotoxin in human plasma. Proc Soc Exp Biol Med 137:334–340, 1971 | PubMed | ChemPort |
  27. Riches DWH, Stanworth DR: A single new method of measuring the capacity to activate the alternative complement pathway. Immunol Letts 1:363–366, 1980
  28. Williams JD, Topley N, Alobaidi HM, Harber MJ: Activation of human polymorphonuclear leucocytes by particulate zymosan is related to both its major carbohydrate components: glucan and mannan. Immunology 58:117–124, 1986 | PubMed | ChemPort |
  29. Williams JD, Czop JK, Austen KF: Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activator. J Immunol 132:3034–3039, 1984
  30. Bretz U, Baggiolini M: Biochemical and morphological characterisation of azurophil and specific granules of human neutrophilic polymorphonuclear leukocytes. J Cell Biol 63:251–269, 1974 | Article | PubMed | ChemPort |
  31. Kane SP, Hoffbrand AV, Neale G: Indices of granulocyte activity in inflammatory bowel disease. Gut 15:953–959, 1974
  32. Mead JAR, Smith JN, Williams RJ: The biosynthesis of the glucoronides of umbelliferone and 4-methylumbelliferone and their use in fluorimetric determination of beta-glucouronidase. Biochem J 61:569–574, 1955
  33. Wroblewski F, LaDue JS: Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med 90:210–213, 1955 | PubMed | ISI | ChemPort |
  34. Lewis RA, Mencia-Huerta J-M, Soberman RJ, Hoover D, Marfat A, Corey EJ, Austen KF: Radioimmunoassay for leukotriene B4. Proc Natl Acad Sci USA 79:7904–7908, 1982 | Article | PubMed | ChemPort |
  35. Rokach J, Hayes EC, Girard Y, Lombardo DL, Maycock AL, Rosenthal AS, Young RN, Zamboni R, Zweerink HJ: The development of sensitive and specific radioimmunoassays for leukotrienes. Prostaglandin Leukotriene Med 13:21–25, 1984
  36. Afonso AM, Charlwood PA, Marshall RD: Isolation and characterisation of glycopeptides from digests of human Tamm-Horsfall glycoprotein. Carbohydrate Res 89:309–319, 1981
  37. Schacterle GR, Pollack RL: A simplified method for the quantitative assay of small amounts of protein in biologic material. Anal Biochem 51:645–655, 1973
  38. Francois C, Marshall RD, Neuberge A: The determination of mannose in hens egg albumin by radioisotope dilution. Biochem J 83:335–341, 1962 | PubMed | ISI | ChemPort |
  39. Warren L: The thiobarbituric acid assay of sialic acids. J Biol Chem 234:1971–1975, 1959 | PubMed | ISI | ChemPort |
  40. Dunstan DR, Grant AMS, Marshall RD, Neuberger A: A protein immunologically similar to Tamm-Horsfall glycoprotein produced by cultured baby hamster kidney cells. Proc Royal Soc London B 186:279–316, 1974
  41. Davies M, Coles GA, Harber MJ: Effect of glomerular basement membrane on the initiation of chemiluminescence and lysosomal enzyme release in human polymorphonuclear leucocytes: An in vitro model of glomerular disease. Immunology 52:151–159, 1984
  42. Brentwood BJ, Henson PM: The sequential release of granule constituents from human neutrophils. J Immunol 124:855–862, 1980
  43. Rent RF, Farrell CF, Nails FL: Mannose inhibits the human neutrophil oxidative burst. J Leukocyte Biol 43:158–164, 1988
  44. Harber MJ, Topley N: Factors affecting the measurement of chemiluminescence in stimulated human polymorphonuclear leucocytes. J Biolumin Chemilumin 1:15–27, 1986
  45. Steadman R, Topley N, Jenner DE, Davies M, Williams JD: Type 1 fimbriate Escherichia coli stimulate a unique pattern of degranulation by human polymorphonuclear leukocytes. Infect Immun 56:815–822, 1988 | PubMed |
  46. Williams JD, Lee TH, Lewis RA, Austen KF: Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan. J Immun 134:2634–2640, 1985
  47. Freeman BA, Crapo JD: Free radicals and tissue injury. Lab Invest 47:412–426, 1982 | PubMed | ISI | ChemPort |
  48. Fantone JS, Ward PA: The role of oxygen derived free-radicals and metabolites in leucocyte-dependent inflammatory reactions. Am J Pathol 107:397–418, 1982 | ISI | ChemPort |
  49. Williams JD, Czop JK, Austen KF: Release of leukotrienes by human monocytes on stimulation of their phagocyte receptor for particulate activators. J Immunol 132:3034–3040, 1984
  50. Hunt JS, McGiven AR: Stimulation of human peripheral blood lymphocytes by Tamm-Horsfall urinary glycoprotein. Immunology 35:391–395, 1978
  51. Serafini-Cessi F, Francesci C, Sperti S: Specific interaction of human Tamm-Horsfall glycoprotein with leucoagglutinin, a lectin from Phaseolus vlugaris (red kidney bean). Biochem J 183:381–388, 1979
  52. Abbodanza A, Francesci C, Licastro F, Serafini-Cessi F: Properties of a glycopeptide isolated from human Tamm-Horsfall glycoprotein. Biochem J 187:525–528, 1980
  53. Hunt JS, MacDonald PR, Day WA, McGiven AR: Biochemical and mitogenic properties of Tamm-Horsfall urinary glycoprotein. Pathology 12:609–621, 1980
  54. Cochrane AMG, Tsantoulas DC, McFarlane IG, Eddleston ALWF, Williams R: The significance of stimulation in leukocyte migration test as an indicator of cellular hypersensitivity studies using Tamm-Horsfall glycoprotein as an antigen. Clin Exp Immunol 31:174–177, 1978
  55. Pennica D, Kohr WJ, Kuang WJ, Glassiter D, Aggarwal BB, Chen EY, Goeddel DV: Identification of human uromodulin as the Tamm-Horsfall urinary glycoprotein. Science 236:83–88, 1987 | Article | PubMed | ISI | ChemPort |
  56. Muchmore AV, Decker JM: Uromodulin: an unique immunosuppressive glycoprotein isolated from urine of pregnant women. Science 229:479–481, 1985 | PubMed | ISI | ChemPort |
  57. Brown KM, Muchmore AV, Rosenstreich DL: Uromodulin, an immunosuppressive protein derived from pregnancy urine, is an inhibitor of interleukin-1. Proc Natl Acad Sci USA 83:9119–9123, 1986 | Article | PubMed | ChemPort |
  58. Muchmore AV, Decker JM: Evidence that recombinant ILa exhibits lectin-like specificity and binds to homogeneous uromodulin via N-linked oligosaccharides. J Immunol 138:2541–2546, 1987
  59. Muchmore AV, Shigin S, Decker JM: In vitro evidence that carbohydrate moieties derived from uromodulin, an 85000 dalton immunosuppressive glycoprotein isolated from human pregnancy urine, are immunosuppressive in the absence of intact protein. J Immunol 138:2547–2553, 1987 | PubMed | ISI | ChemPort |
  60. Sherblom AP, Decker JM, Muchmore AV: The lectin-like interaction between recombinant tumour necrosis factor and uromodulin. J Biol Chem 263:5418–5424, 1988 | PubMed | ISI | ChemPort |
  61. McQueen EG: The nature of urinary casts. J Clin Pathol 15:367–373, 1962 | ISI | ChemPort |
  62. Scurr DS, Robertson WG: Modifiers of calcium oxalate crystallization found in urine. III Studies on the role of Tamm-Horsfall mucoprotein and of ionic strength. J Urol 136:505–507, 1986

Extra navigation

.
ADVERTISEMENT